TRMK

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

High

33.610

Open

33.590

VWAP

33.57

Vol

113.08K

Mkt Cap

2.02B

Low

33.480

Amount

3.80M

EV/EBITDA(TTM)

28.46

Total Shares

61.20M

2.39B

EV/OCF(TTM)

P/S(TTM)

4.83

Trustmark Corporation is a bank holding company. The Company's principal subsidiary is Trustmark National Bank (TNB). Through TNB and its subsidiaries, the Company operates as a financial services company providing banking and other financial solutions. The Company operates through three segments: General Banking, Wealth Management and Insurance. The General Banking Segment is responsible for all traditional banking products and services, including loans and deposits. The Wealth Management Segment provides customized solutions for customers by integrating financial services with traditional banking products and services, such as money management, full-service brokerage, financial planning, personal and institutional trust and retirement services. Through Fisher Brown Bottrell Insurance, Inc. (FBBI), a subsidiary of TNB, the Insurance Segment provides a range of retail insurance products, including commercial risk management products, bonding, group benefits and personal lines coverage.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

198.98M

+10.99%

0.860

+30.3%

201.40M

+4.75%

0.868

+3.27%

202.85M

+1.73%

0.877

-4.62%

Estimates Revision

The market is revising Downward the revenue expectations for Trustmark Corporation (TRMK) for FY2025, with the revenue forecasts being adjusted by -0.85% over the past three months. During the same period, the stock price has changed by -8.16%.

Revenue Estimates for FY2025

Revise Downward

-0.85%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.41%

In Past 3 Month

Stock Price

Go Down

-8.16%

In Past 3 Month

4 Analyst Rating

25.97% Upside

Wall Street analysts forecast TRMK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TRMK is 42.25 USD with a low forecast of 39.00 USD and a high forecast of 47.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

2 Hold

0 Sell

Moderate Buy

25.97% Upside

Current: 33.540

Low

39.00

Averages

42.25

High

47.00

25.97% Upside

Current: 33.540

Low

39.00

Averages

42.25

High

47.00

Keefe, Bruyette & Woods

Catherine Mealor

Buy

Maintains

$45 → $43

2025-04-24

New

Reason

Keefe, Bruyette & Woods

Catherine Mealor

Price Target

$45 → $43

2025-04-24

New

Maintains

Buy

Reason

Keefe Bruyette lowered the firm's price target on Trustmark to $43 from $45 and keeps an Outperform rating on the shares.

Keefe, Bruyette & Woods

Catherine Mealor

Buy

Maintains

$45 → $47

2025-02-03

Reason

Keefe, Bruyette & Woods

Catherine Mealor

Price Target

$45 → $47

2025-02-03

Maintains

Buy

Reason

DA Davidson

Gary Tenner

Hold

Maintains

$40 → $41

2025-01-30

Reason

DA Davidson

Gary Tenner

Price Target

$40 → $41

2025-01-30

Maintains

Hold

Reason

DA Davidson analyst Gary Tenner raised the firm's price target on Trustmark to $41 from $40 and keeps a Neutral rating on the shares. The company reported a pretax beat, with strong fee income and lower expenses seen as the primary drivers, and the firm expects continued net interest margin expansion in 2025 given a combined loan repricing tailwind and lower funding costs, the analyst tells investors in a research note.

Janney Montgomery Scott

Christopher Marinac

Strong Buy

Initiates

$42

2025-01-24

Reason

Janney Montgomery Scott

Christopher Marinac

Price Target

$42

2025-01-24

Initiates

Strong Buy

Reason

Janney Montgomery Scott initiated coverage of Trustmark with a Buy rating and $42 fair value estimate. Trustmark should generate a 1.00% return on assets or better, with 9%-10% annual tangible book value per share growth in both 2025 and 2026, the analyst tells investors in a research note. The firm believes external expansion is possible through M&A, although organic growth is most likely in the near-term.

Truist Securities

Brandon King

Hold

Maintains

$35 → $36

2024-10-25

Reason

Truist Securities

Brandon King

Price Target

$35 → $36

2024-10-25

Maintains

Hold

Reason

DA Davidson

Gary Tenner

Hold

Maintains

$35 → $38

2024-10-24

Reason

DA Davidson

Gary Tenner

Price Target

$35 → $38

2024-10-24

Maintains

Hold

Reason

DA Davidson analyst Gary Tenner raised the firm's price target on Trustmark to $38 from $35 and keeps a Neutral rating on the shares. The company's Q3 earnings beat was highlighted by stronger than expected spread income on stronger than expected net interest margin expansion, the analyst tells investors in a research note. While maintaining strong capital with CET1 of 11.3%, Trustmark is unlikely to utilize its buyback, preferring to utilize capital for organic growth and potential inorganic opportunities, the firm added.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Trustmark Corp (TRMK.O) is 9.67, compared to its 5-year average forward P/E of 12.00. For a more detailed relative valuation and DCF analysis to assess Trustmark Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

12.00

Current PE

9.67

Overvalued PE

14.27

Undervalued PE

9.73

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.56

Current PS

2.53

Overvalued PS

3.01

Undervalued PS

2.10